Compare · SGFY vs WGS
SGFY vs WGS
Side-by-side comparison of Signify Health Inc. (SGFY) and GeneDx Holdings Corp. (WGS): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both SGFY and WGS operate in Retail: Computer Software & Peripheral Equipment (Technology), so they compete in similar markets.
- WGS is the larger of the two at $2.71B, about 1.3x SGFY ($2.12B).
- WGS has hit the wire 9 times in the past 4 weeks while SGFY has been quiet.
- SGFY has more recent analyst coverage (13 ratings vs 8 for WGS).
- Company
- Signify Health Inc.
- GeneDx Holdings Corp.
- Price
- $30.50+0.07%
- $90.68-7.28%
- Market cap
- $2.12B
- $2.71B
- 1M return
- -
- +4.09%
- 1Y return
- -
- -25.37%
- Industry
- Retail: Computer Software & Peripheral Equipment
- Retail: Computer Software & Peripheral Equipment
- Exchange
- NYSE
- NASDAQ
- IPO
- 2021
- 2020
- News (4w)
- 0
- 9
- Recent ratings
- 13
- 8
Signify Health Inc.
Signify Health, Inc. operates a healthcare platform that utilizes analytics, technology, and healthcare provider networks in the United States. The company operates in two segments, Home & Community Services and Episodes of Care Services. The Home & Community Services segment offers health evaluations performed within the patient's home or at a healthcare provider facility primarily to Medicare Advantage health plans; diagnostic screening and other ancillary services; and services to address healthcare concerns related to social determinants of health. The Episodes of Care Services segment provides services to enhance the healthcare delivery through developing and managing episodic payment programs in partnership with healthcare providers primarily under the Medicare Bundled Payment for Care Improvement Advanced program with Centers for Medicare and Medicaid Services; and care management services. Its customers include health plans, governments, employers, health systems, and physician groups. The company was founded in 2017 and is headquartered in Dallas, Texas with additional offices in Austin, New York, Norwalk, and Rapid City.
Latest SGFY
- UnitedHealth Group, CVS Health, Oracle, And This US Shale Oil Titan Ignite CNBC's 'Final Trades' Showdown
- SEC Form 15-12G filed by Signify Health Inc.
- SEC Form 25-NSE filed by Signify Health Inc.
- SEC Form 4 filed by Builder Josh
- SEC Form S-8 POS filed by Signify Health Inc.
- SEC Form 4 filed by Armbrester Bradford Kyle
- SEC Form 4 filed by Rothman Marc D
- SEC Form 4 filed by Notini Albert A
- SEC Form 4 filed by Dixon Heather Brianne
- SEC Form 4 filed by Senneff Steve
Latest WGS
- CHIEF EXECUTIVE OFFICER Stueland Katherine converted options into 18,750 shares and sold $1,025,013 worth of shares (10,501 units at $97.61), increasing direct ownership by 8% to 115,476 units (SEC Form 4) (withholding obligation)
- CHIEF FINANCIAL OFFICER Feeley Kevin converted options into 7,197 shares and sold $363,892 worth of shares (3,728 units at $97.61), increasing direct ownership by 8% to 44,945 units (SEC Form 4) (tax withholding)
- Director Fuchs Thomas converted options into 1,146 shares (SEC Form 4)
- CHIEF EXECUTIVE OFFICER Stueland Katherine converted options into 6,547 shares and sold $310,932 worth of shares (3,692 units at $84.22), increasing direct ownership by 3% to 107,227 units (SEC Form 4) to cover taxes
- CHIEF FINANCIAL OFFICER Feeley Kevin converted options into 2,462 shares and sold $108,220 worth of shares (1,285 units at $84.22), increasing direct ownership by 3% to 41,476 units (SEC Form 4) to satisfy tax liability
- GeneDx and Beren Therapeutics Launch NPC GenomeComplete to Improve Diagnosis of Niemann-Pick Disease Type C
- CHIEF FINANCIAL OFFICER Feeley Kevin converted options into 717 shares and sold $31,188 worth of shares (372 units at $83.84), increasing direct ownership by 0.86% to 40,299 units (SEC Form 4) to cover taxes
- SEC Form 144 filed by GeneDx Holdings Corp.
- GeneDx CEO Katherine Stueland Recognized as a 2026 Fierce 50 Honoree
- GeneDx Announces Transformative Study Supporting Hospital-Wide Adoption of Rapid Genomic Sequencing at Seattle Children’s